<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "PACLitaxel inj VIAL>
<dose><value>200</value>
<value>50</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>PACLitaxel inj VIAL</value>
</drugname><strength><value>6 mg/mL</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>DAY 1 of 21. Administer dose diluted in 500 mL 0.9% sodium chloride over 3 hours. Start infusion at 100 mL/hour for 15 minutes, then resume ordered infusion rate.</value>
<value>DAY 1 of 7. Administer dose diluted in 100 to 250 mL 0.9% sodium chloride over 1 hour. Invert bag gently approximately 6 times prior to administration. Use a non-DEHP line with a 0.2 or 0.22 micron in-line filter for administration.</value>
</instruction><volume><value>16.7 mL</value>
<value>5 mL</value>
<value>50 mL</value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x109/L: Delay 1 week.</value>
<value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x109/L: Hold chemotherapy and contact physician.</value>
<value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x109/L: Hold chemotherapy and contact physician.  </value>
</additionalnotes><population><value>Adjuvant PACLitaxel/CARBOplatin. Non-Small Cell Lung Cancer</value>
<value>PACLitaxel / CARBOplatin. Advanced / Metastatic Non-Small Cell Lung Cancer</value>
<value>PACLitaxel/CARBOplatin (Weekly) and concurrent RT. Non-Small Cell Lung Cancer.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>Invert bag gently approximately 6 times prior to administration. Use a non-DEHP line with a 0.2 to 0.22 micron in-line filter for administration.</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3432</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>